New drug cocktail shows promise in shrinking advanced melanoma before surgery
NCT ID NCT07586904
First seen May 22, 2026 · Last updated May 22, 2026
Summary
This early-phase trial tests whether combining cadonilimab with high-dose interferon before surgery can shrink tumors in people with stage III or IV melanoma. About 10 participants will receive the treatment and be monitored for side effects and tumor response. The goal is to gather initial safety and effectiveness data to support larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA (SKIN CANCER) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Xijing Hospital, Air Force Medical University Xi'an, Shaanxi, China
RECRUITINGXi'an, China
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.